Following repeated TACE procedures, TACE failure/refractory effects often occur [19], leading to a poor tumour response and damaged liver function, eventually causing the upregulation of vascular endothelial growth factor (VEGF) and hypoxia inducible factor (HIF) expression and ultimately reducing the OS rate. The gene discussed is VEGFA; the disease is neoplasm.